US FDA approves Enspryng from Genentech for neuromyelitis optica spectrum disorder EP News Bureau Aug 16, 2020 In two randomised controlled Phase III clinical trials, SAkuraStar and SAkuraSky studies, Enspryng demonstrated robust and…
US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production EP News Bureau Jul 25, 2020 The approval granted through a business review letter from the Justice Department's antitrust division, however, has not allowed…
